文献速递瘢痕与激光

病灶内冷冻疗法对比切除联合皮质类固醇注射或近距离放射治疗瘢痕疙瘩:随机对照试验

Intralesional cryotherapy versus excision with corticosteroid injections or brachytherapy for keloid treatment: Randomised controlled trials.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2018-02-06

两项多中心随机对照开放试验比较病灶内冷冻疗法与切除联合皮质类固醇注射(原发性瘢痕疙瘩)或切除联合近距离放射治疗(难治性瘢痕疙瘩)。因冷冻疗法结果意外较差,纳入26例后提前终止。难治性瘢痕疙瘩中,切除联合近距离放射治疗显著改善瘢痕外观(POSAS)及瘙痒、疼痛,冷冻疗法无此效果;原发性瘢痕疙瘩组样本过小无法得出有效结论。

要点

  • 难治性瘢痕疙瘩:切除联合近距离放射治疗显著改善POSAS及瘙痒、疼痛,冷冻疗法未显示改善。
  • 原发性瘢痕疙瘩:冷冻疗法可缩小瘢痕体积,但组样本过小无法得出有效结论。
  • 因冷冻疗法结果意外较差,试验纳入26例后提前终止。

核心结论

  • 对于难治性瘢痕疙瘩,病灶内冷冻疗法劣于切除联合近距离放射治疗。
  • 对于原发性瘢痕疙瘩,病灶内冷冻疗法可缩小瘢痕体积,因此可用于这些患者及特定病例;但原发性瘢痕疙瘩组样本量过小,无法得出有效结论,需进一步研究病灶内冷冻疗法对原发性瘢痕疙瘩的疗效。

研究设计与样本

  • 两项多中心、随机对照、开放试验:1)比较病灶内冷冻疗法与切除联合皮质类固醇注射治疗原发性瘢痕疙瘩;2)比较病灶内冷冻疗法与切除联合近距离放射治疗治疗难治性瘢痕疙瘩。
  • 主要结局为采用患者与观察者瘢痕评估量表(POSAS)评估的瘢痕外观;次要结局为患者报告的生活质量(Skindex-29、SF-36、EQ-5D-5L)、复发率及瘢痕体积缩小。
  • 分析采用线性混合模型;功效分析提示每组需33例患者;因冷冻疗法结果意外较差,纳入26例后试验提前终止。

主要发现

  • 原发性瘢痕疙瘩:两种治疗间未发现令人信服的差异,但手术改善了瘢痕外观而冷冻疗法未改善。
  • 难治性瘢痕疙瘩:切除联合近距离放射治疗显著改善瘢痕外观(POSAS)及瘢痕症状(瘙痒和疼痛),分别为p < 0.001、p < 0.001和p = 0.006;冷冻疗法未显示改善。
  • 两种治疗均未使生活质量获得无可争议的改善。

临床怎么用

  • 作者认为,对于难治性瘢痕疙瘩,病灶内冷冻疗法劣于切除联合近距离放射治疗。
  • 作者认为,对于原发性瘢痕疙瘩,病灶内冷冻疗法可缩小瘢痕体积,因此可用于这些患者及特定病例;原发性瘢痕疙瘩组样本量过小无法得出有效结论,需进一步研究病灶内冷冻疗法对原发性瘢痕疙瘩的疗效。

局限性

  • 因冷冻疗法结果意外较差,试验纳入26例后提前终止。
  • 原发性瘢痕疙瘩组样本量过小,无法得出有效结论。
  • 需进一步研究病灶内冷冻疗法对原发性瘢痕疙瘩的疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Keloids are a burden for patients due to physical, aesthetic and social consequences. Treatment remains a challenge due to therapy resistance and high recurrence rates. The main goals of treatment are to improve scar appearance and symptoms and patients' quality of life (QoL). METHODS: Two multicentre, randomised controlled open trials that compared 1) intralesional cryotherapy with excision and corticosteroid injections for primary keloids, and 2) intralesional cryotherapy with excision and brachytherapy for therapy resistant keloids. Primary outcome was scar appearance assessed with the Patient and Observer Scar Assessment Scale. Secondary outcomes were patient reported QoL (Skindex-29, SF-36, EQ-5D-5L), recurrence rates and scar volume reduction. For analysis, a linear mixed model was used. Power analysis indicated 33 patients in each group were needed. RESULTS: The trial was prematurely terminated after inclusion of 26 patients due to unexpectedly inferior outcomes after intralesional cryotherapy. For primary keloids no convincing difference between treatments was found, but surgery improved scar appearance while cryotherapy did not. For resistant keloids, excision followed by brachytherapy improved scar appearance (POSAS) and scar symptoms (itch and pain) significantly (p < 0.001, p < 0.001 and p = 0.006 respectively) while cryotherapy did not. Neither of the treatments caused indisputable improvements in QoL. CONCLUSIONS: Intralesional cryotherapy is inferior to keloid excision followed by brachytherapy for resistant keloids. In primary keloids, intralesional cryotherapy reduced keloid volume and, therefore, may be used in these patients and specific cases. Primary keloid group size was too small to draw valid conclusions, further research on the efficacy of intralesional cryotherapy for primary keloids is warranted.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Bijlard E, Timman R, Verduijn GM, et al. Intralesional cryotherapy versus excision with corticosteroid injections or brachytherapy for keloid treatment: Randomised controlled trials. J Plast Reconstr Aesthet Surg. 2018. PMID: 29426811. doi:10.1016/j.bjps.2018.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。